Bicycle Therapeutics PLC reports results for the quarter ended in June - Earnings Summary

Bicycle Therapeutics

05/08/2021 19:35

* Bicycle Therapeutics PLC  BCYC.OQ  reported a quarterly
adjusted loss of 74 cents​​ per share for the quarter ended in
June. The mean expectation of nine analysts for the quarter was
for a loss of 73 cents per share.
* Revenue rose 13.6% to $1.79 million from a year ago;  analysts
expected $2.31 million. 
* Bicycle Therapeutics PLC's reported EPS for the quarter was a
loss of 74 cents​.
* The mean earnings estimate of analysts had risen by about 6.9%
in the last three months.​ 
* In the last 30 days three analysts negatively revised earnings
estimates 
* Bicycle Therapeutics PLC shares had fallen by 3.1% this
quarter and gained 63.8% so far this year.
* The company reported a quarterly loss of $17.91 million.
* Wall Street's median 12-month price target for Bicycle
Therapeutics PLC is $42.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 5 at 06:35 p.m.  ​All
figures in US dollars unless otherwise stated